AQST PDUFA decision: a negative outcome, -3.0%

On February 10, 2026, Aquestive Therapeutics, Inc. reached its PDUFA decision. The result was a negative outcome, and the stock moved -3.0% in the window around the event. It had already run -35.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.